Related Experiment Video
Updated: Jun 21, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Pathophysiology of chronic heart failure
Mariana Seixas-Cambão1, Adelino F Leite-Moreira
1Serviço de Fisiologia da Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Summary
Heart failure involves reduced cardiac output and increased venous pressure due to molecular changes. Understanding the body's neurohumoral response is key to developing pharmacological treatments for this condition.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Heart failure is characterized by reduced cardiac output (CO) and increased venous pressure.
- It involves molecular changes leading to cardiac muscle cell damage and death.
- The body's neurohumoral response attempts to increase CO but contributes to the condition.
Purpose of the Study:
- To synthesize data on the mechanisms driving heart failure progression.
- To clarify the relationships between biological agents involved in heart failure.
- To identify targets for pharmacological modification in heart failure treatment.
Main Methods:
- Review of existing literature on neurohumoral mechanisms in heart failure.
- Analysis of molecular and cellular changes associated with heart failure.
- Examination of regulatory and counter-regulatory neurohumoral pathways.
Main Results:
- The neurohumoral response includes hemodynamic, inflammatory, and hypertrophic/remodeling elements.
- Regulatory mechanisms increase vasoconstriction and sodium retention, while counter-regulatory mechanisms have opposite effects.
- These neurohumoral pathways are ultimately responsible for the progression of heart failure.
Conclusions:
- Elucidating the complex interplay of biological agents in heart failure is crucial.
- Identifying pharmacologically modifiable targets within the neurohumoral response is essential for effective treatment.
- A comprehensive understanding of these mechanisms can guide the development of novel therapies for heart failure.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...